Avivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017
April 26, 2017 15:28 ET
|
Avivagen Inc.
OTTAWA, April 26, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...
Avivagen Announces Results From Its Annual and Special Meeting of Shareholders
April 12, 2017 09:26 ET
|
Avivagen Inc.
OTTAWA, April 12, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...
Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection
April 10, 2017 07:42 ET
|
Avivagen Inc.
OTTAWA, April 10, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...
Avivagen Announces a Follow-On Purchase Order of OxC-Beta™ Livestock From UNAHCO, Inc.
April 06, 2017 11:45 ET
|
Avivagen Inc.
OTTAWA, April 06, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent protected product intended...